Fondazione Banca degli Occhi del Veneto

Fondazione Banca degli Occhi del Veneto (FBOV) is a leading European eye bank and research center dedicated to the treatment of ocular surface diseases and corneal blindness. Based in Venice, Italy, the foundation operates as a non-profit organization that collects, processes, and distributes human ocular tissue for transplantation. FBOV is globally recognized for its pioneering work in regenerative medicine, particularly the development of Holoclar, the first stem-cell-based product approved in the European Union for treating limbal stem cell deficiency. The foundation integrates clinical services with advanced research in biotechnology and tissue engineering to improve surgical outcomes and patient quality of life. It operates a state-of-the-art GMP-certified cell factory for the production of advanced therapy medicinal products.